Ultragenyx Pharmaceutical Inc
For the period ended Sep 30, 2024. Filed Nov 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 6, 2024
RARE$16.41+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | Date | Number | Furnished or Filed Herewith |
| 3.1 | Amended and Restated Certificate of Incorporation | 8-K | 2/5/2014 | 3.1 | |
| 3.2 | Second Amended and Restated Bylaws | 8-K | 12/23/2023 | 3.1 | |
| 4.1 | Form of Common Stock Certificate | S-1 | 11/8/2013 | 4.2 | |
| 4.2 | Form of Indenture | S-3ASR | 2/21/2024 | 4.2 | |
| 4.3 | Form of Pre-Funded Warrant | 8-K | 10/23/2023 | 4.1 | |
| 4.4 | Form of Pre-Funded Warrant | 8-K | 6/17/2024 | 4.1 | |
| 31.1 | Certification of Principal Executive Officer Required Under Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act | X | |||
| 31.2 | Certification of Principal Financial Officer Required Under Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act | X | |||
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and 18 U.S.C. 1350 | X | |||
| 101.INS | XBRL Instance Document, formatted in Inline XBRL | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | |||
| 104 | Cover Page Interactive Data File, formatted in Inline XBRL (included in Exhibit 101). | ||||
- The certification attached as Exhibit 32.1 that accompanies this Quarterly Report is furnished to, and not deemed filed with, the SEC and is not to be incorporated by reference into any filing of the Registrant under the Securities Act or the Exchange Act, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.